Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine

Microbial Drug Resistance

Volumn 14, Issue 2, 2008, Pages 101-107

  Mera, Robertino ^a,c   Miller, Linda A ^a   Fritsche, Thomas R ^b   Jones, Ronald N ^b  

^a GLAXOSMITHKLINE   (United States)

^b JMI LABORATORIES   (United States)

^c MAI B2522E ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG SURVEILLANCE PROGRAM; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION; ADOLESCENT; ADULT; AGED; CLASSIFICATION; DRUG EFFECT; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFANT; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SEROTYPING; STREPTOCOCCUS INFECTION;

STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL VACCINES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 50149115661     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0782     Document Type: Article

References (23)

1. Black, S., H. Shinefield, B. Fireman, et al. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19:187-195.
2. Dagan, R., N. Givon-Lavi, O. Zamir, et al. 2002. Reduction of pneumococcal carriage in DCCs. J. Infect. Dis. 185:927-936.
3. Centers for Disease Control and Prevention (CDC). 2005. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb. Mortal. Wkly. Rep. 54:893-897.
4. Frazao, N., A. Brito-Avo, C. Simas, et al. 2005. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr. Infect. Dis. J. 24:243-252.
5. Garbutt, J., I. Rosenbloom, J. Wu, and G.A. Storch. 2006. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine. Pediatrics 117:1087-1094.
6. Ghaffar, F., T. Barton, J. Lozano, et al. 2004. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin. Infect. Dis. 39:930-938.
7. Gonzales, B.E., K.G. Hulten, L. Lamberth, S.L. Kaplan, and E.O. Mason. 2006. Streptococcus pneumoniae serogroups 15 and 33. An increasing cause of pneumococcal infections in children in the United States after the introduction of the Pnuemococcal 7 valent conjugate vaccine. Pediatr. Infect. Dis. J. 25:301-305.
8. Jones, R.N. 2003. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin. Respir. Crit. Care Med. 2:121-134.
9. Jones, R.N., H.S. Sader, T.R. Fritsche, and S. Pottumarthy. 2007. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn. Microbiol. Infect. Dis. 57:109-116.
10. Kyaw, M.H., R. Lynfield, W. Schaffner, et al. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455-1463.
11. Lexau, C., R. Lynfield, R. Danila, T. Pilshvili, R. Fackalm et al. 2005. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294:2043-2051.
12. Mbelle, N., R.E. Huebner, A.D. Wasas, A. Kimura, I. Chang, and K.P. Klugman. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180:1171-1176.
13. Mera, R.M., L. Miller, T.R. Fritsche, and R.N. Jones. 2006. A mathematical model for the impact of the conjugate vaccine on S. pneumoniae vaccine and non-vaccine serotypes. Presentation # 478. Program of the 44th Annual Meeting of the Infectious Diseases Society of America, Ontario, Canada.
14. Messina, A.F., K. Katz-Gaynor, T. Barton, N. Ahmad, F. Ghaffar, D. Rasko, and G.H. McCracken, Jr. 2007. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr. Infect. Dis. J. 26:461-467.
15. Centers for Disease Control and Prevention (CDC). 2006. National, state, and urban area vaccination coverage among children aged 19-35 months - United States. 2005. MMWR Morb. Mortal. Wkly. Rep. 55:988-993.
16. Pai, R., M. Moore, T. Pilishvili, R. Gertz, et al. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995.
17. Pelton, S.I., A.M. Loughlin, and C.D. Marchant. 2004. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities. Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr. Infect. Dis. J. 23:1015-1022.
18. Poehling, K., T. Talbot, M, Griffin, A. Craig, et al. 2006. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 295:1668-1674.
19. Porat, N., A. Arguedas, B.G. Spratt, et al. 2004. Emergence of penicillin nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J. Infect. Dis. 190:2154-2161.
20. Steenhoff, A.P., S.S. Shah, A.J. Ratner, S.M. Patil, and K.L. McGowan. 2006. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin. Infect. Dis. 42:907-914.
21. Stephens, D., S. Zughaier, C. Whitney, W. Baughman, et al. 2005. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365:855-863.
22. Talbot, T.R., K.A. Poehling, T.V. Hartert, et al. 2004. Reduction in high rates of antibiotic- nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 39:641-648.
23. Temime, L., D. Guillemot, and P.Y. Boëlle. 2004. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob. Agents Chemother. 48:2206-2213.